Study of ONO-7914 Alone and in Combination With ONO-4538 in Patients With Solid Tumors
Clinical trial NCT06535009 · TERMINATED
Trial details
- NCT number
- NCT06535009
- Sponsor
- Ono Pharmaceutical Co., Ltd.
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-02-08
- Primary completion
- 2025-02-26
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.